Financhill
Buy
56

LNSR Quote, Financials, Valuation and Earnings

Last price:
$11.78
Seasonality move :
5.22%
Day range:
$11.33 - $12.00
52-week range:
$8.96 - $17.31
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.34x
P/B ratio:
33.92x
Volume:
57.6K
Avg. volume:
39.4K
1-year change:
18.2%
Market cap:
$139.6M
Revenue:
$53.5M
EPS (TTM):
-$4.39

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
LNSR
LENSAR, Inc.
$20.5M -$0.09 30.98% -90.51% $15.00
LAB
Standard BioTools, Inc.
$18.5M -$0.03 -54.41% -72.53% $1.55
LUDG
Ludwig Enterprises, Inc.
-- -- -- -- --
OPGN
OpGen, Inc.
-- -- -- -- --
USAQ
QHSLab, Inc.
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
LNSR
LENSAR, Inc.
$11.69 $15.00 $139.6M -- $0.00 0% 2.34x
LAB
Standard BioTools, Inc.
$1.13 $1.55 $434.6M -- $0.00 0% 3.32x
LUDG
Ludwig Enterprises, Inc.
$0.0221 -- $3.6M -- $0.00 0% 37,130.15x
OPGN
OpGen, Inc.
$23.9900 -- $241.6M 59.99x $0.00 0% 26.93x
USAQ
QHSLab, Inc.
$0.6734 -- $7.6M -- $0.00 0% 3.39x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
LNSR
LENSAR, Inc.
-31.16% -1.239 1.79% 0.65x
LAB
Standard BioTools, Inc.
6.41% 0.841 5.49% 1.93x
LUDG
Ludwig Enterprises, Inc.
-144.65% -0.654 24.05% 0.00x
OPGN
OpGen, Inc.
16.9% -36,920.421 205167.16% 5.70x
USAQ
QHSLab, Inc.
162.97% -1.888 73.75% 0.17x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
LNSR
LENSAR, Inc.
$5.8M -$7.6M -684.94% -1013.45% -52.95% -$3.5M
LAB
Standard BioTools, Inc.
$9.5M -$23.5M -22.34% -24.44% -120.02% -$23.1M
LUDG
Ludwig Enterprises, Inc.
-- -$371.4K -- -- -419868.12% -$139.1K
OPGN
OpGen, Inc.
-$48.1K -$702.2K 70.06% 89.47% -5625.96% -$333.3K
USAQ
QHSLab, Inc.
$475.6K $96.3K -35.74% -- 13.05% $2.6K

LENSAR, Inc. vs. Competitors

  • Which has Higher Returns LNSR or LAB?

    Standard BioTools, Inc. has a net margin of -25.94% compared to LENSAR, Inc.'s net margin of -162.05%. LENSAR, Inc.'s return on equity of -1013.45% beat Standard BioTools, Inc.'s return on equity of -24.44%.

    Company Gross Margin Earnings Per Share Invested Capital
    LNSR
    LENSAR, Inc.
    40.56% -$0.31 -$9.2M
    LAB
    Standard BioTools, Inc.
    48.51% -$0.09 $427M
  • What do Analysts Say About LNSR or LAB?

    LENSAR, Inc. has a consensus price target of $15.00, signalling upside risk potential of 28.32%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.55 which suggests that it could grow by 37.17%. Given that Standard BioTools, Inc. has higher upside potential than LENSAR, Inc., analysts believe Standard BioTools, Inc. is more attractive than LENSAR, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    LNSR
    LENSAR, Inc.
    0 2 0
    LAB
    Standard BioTools, Inc.
    1 2 0
  • Is LNSR or LAB More Risky?

    LENSAR, Inc. has a beta of 0.687, which suggesting that the stock is 31.253% less volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.290, suggesting its more volatile than the S&P 500 by 28.967%.

  • Which is a Better Dividend Stock LNSR or LAB?

    LENSAR, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LENSAR, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios LNSR or LAB?

    LENSAR, Inc. quarterly revenues are $14.3M, which are smaller than Standard BioTools, Inc. quarterly revenues of $19.6M. LENSAR, Inc.'s net income of -$3.7M is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, LENSAR, Inc.'s price-to-earnings ratio is -- while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LENSAR, Inc. is 2.34x versus 3.32x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    LNSR
    LENSAR, Inc.
    2.34x -- $14.3M -$3.7M
    LAB
    Standard BioTools, Inc.
    3.32x -- $19.6M -$31.7M
  • Which has Higher Returns LNSR or LUDG?

    Ludwig Enterprises, Inc. has a net margin of -25.94% compared to LENSAR, Inc.'s net margin of -427991.3%. LENSAR, Inc.'s return on equity of -1013.45% beat Ludwig Enterprises, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    LNSR
    LENSAR, Inc.
    40.56% -$0.31 -$9.2M
    LUDG
    Ludwig Enterprises, Inc.
    -- -- -$1.4M
  • What do Analysts Say About LNSR or LUDG?

    LENSAR, Inc. has a consensus price target of $15.00, signalling upside risk potential of 28.32%. On the other hand Ludwig Enterprises, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that LENSAR, Inc. has higher upside potential than Ludwig Enterprises, Inc., analysts believe LENSAR, Inc. is more attractive than Ludwig Enterprises, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    LNSR
    LENSAR, Inc.
    0 2 0
    LUDG
    Ludwig Enterprises, Inc.
    0 0 0
  • Is LNSR or LUDG More Risky?

    LENSAR, Inc. has a beta of 0.687, which suggesting that the stock is 31.253% less volatile than S&P 500. In comparison Ludwig Enterprises, Inc. has a beta of 2.470, suggesting its more volatile than the S&P 500 by 146.979%.

  • Which is a Better Dividend Stock LNSR or LUDG?

    LENSAR, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ludwig Enterprises, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LENSAR, Inc. pays -- of its earnings as a dividend. Ludwig Enterprises, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios LNSR or LUDG?

    LENSAR, Inc. quarterly revenues are $14.3M, which are larger than Ludwig Enterprises, Inc. quarterly revenues of --. LENSAR, Inc.'s net income of -$3.7M is lower than Ludwig Enterprises, Inc.'s net income of $31.3K. Notably, LENSAR, Inc.'s price-to-earnings ratio is -- while Ludwig Enterprises, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LENSAR, Inc. is 2.34x versus 37,130.15x for Ludwig Enterprises, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    LNSR
    LENSAR, Inc.
    2.34x -- $14.3M -$3.7M
    LUDG
    Ludwig Enterprises, Inc.
    37,130.15x -- -- $31.3K
  • Which has Higher Returns LNSR or OPGN?

    OpGen, Inc. has a net margin of -25.94% compared to LENSAR, Inc.'s net margin of -5629.82%. LENSAR, Inc.'s return on equity of -1013.45% beat OpGen, Inc.'s return on equity of 89.47%.

    Company Gross Margin Earnings Per Share Invested Capital
    LNSR
    LENSAR, Inc.
    40.56% -$0.31 -$9.2M
    OPGN
    OpGen, Inc.
    55.51% -$0.06 $12.2M
  • What do Analysts Say About LNSR or OPGN?

    LENSAR, Inc. has a consensus price target of $15.00, signalling upside risk potential of 28.32%. On the other hand OpGen, Inc. has an analysts' consensus of -- which suggests that it could grow by 25.05%. Given that LENSAR, Inc. has higher upside potential than OpGen, Inc., analysts believe LENSAR, Inc. is more attractive than OpGen, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    LNSR
    LENSAR, Inc.
    0 2 0
    OPGN
    OpGen, Inc.
    0 0 0
  • Is LNSR or OPGN More Risky?

    LENSAR, Inc. has a beta of 0.687, which suggesting that the stock is 31.253% less volatile than S&P 500. In comparison OpGen, Inc. has a beta of -3,423.037, suggesting its less volatile than the S&P 500 by 342403.692%.

  • Which is a Better Dividend Stock LNSR or OPGN?

    LENSAR, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OpGen, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LENSAR, Inc. pays -- of its earnings as a dividend. OpGen, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios LNSR or OPGN?

    LENSAR, Inc. quarterly revenues are $14.3M, which are larger than OpGen, Inc. quarterly revenues of --. LENSAR, Inc.'s net income of -$3.7M is lower than OpGen, Inc.'s net income of -$608.7K. Notably, LENSAR, Inc.'s price-to-earnings ratio is -- while OpGen, Inc.'s PE ratio is 59.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LENSAR, Inc. is 2.34x versus 26.93x for OpGen, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    LNSR
    LENSAR, Inc.
    2.34x -- $14.3M -$3.7M
    OPGN
    OpGen, Inc.
    26.93x 59.99x -- -$608.7K
  • Which has Higher Returns LNSR or USAQ?

    QHSLab, Inc. has a net margin of -25.94% compared to LENSAR, Inc.'s net margin of 4.53%. LENSAR, Inc.'s return on equity of -1013.45% beat QHSLab, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    LNSR
    LENSAR, Inc.
    40.56% -$0.31 -$9.2M
    USAQ
    QHSLab, Inc.
    64.52% $0.00 $970.2K
  • What do Analysts Say About LNSR or USAQ?

    LENSAR, Inc. has a consensus price target of $15.00, signalling upside risk potential of 28.32%. On the other hand QHSLab, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that LENSAR, Inc. has higher upside potential than QHSLab, Inc., analysts believe LENSAR, Inc. is more attractive than QHSLab, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    LNSR
    LENSAR, Inc.
    0 2 0
    USAQ
    QHSLab, Inc.
    0 0 0
  • Is LNSR or USAQ More Risky?

    LENSAR, Inc. has a beta of 0.687, which suggesting that the stock is 31.253% less volatile than S&P 500. In comparison QHSLab, Inc. has a beta of 0.510, suggesting its less volatile than the S&P 500 by 48.993%.

  • Which is a Better Dividend Stock LNSR or USAQ?

    LENSAR, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. QHSLab, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LENSAR, Inc. pays -- of its earnings as a dividend. QHSLab, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios LNSR or USAQ?

    LENSAR, Inc. quarterly revenues are $14.3M, which are larger than QHSLab, Inc. quarterly revenues of $737.1K. LENSAR, Inc.'s net income of -$3.7M is lower than QHSLab, Inc.'s net income of $33.4K. Notably, LENSAR, Inc.'s price-to-earnings ratio is -- while QHSLab, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LENSAR, Inc. is 2.34x versus 3.39x for QHSLab, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    LNSR
    LENSAR, Inc.
    2.34x -- $14.3M -$3.7M
    USAQ
    QHSLab, Inc.
    3.39x -- $737.1K $33.4K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 21

RingCentral, Inc. [RNG] is up 34.37% over the past day.

Sell
9
FROG alert for Feb 21

JFrog Ltd. [FROG] is down 24.98% over the past day.

Buy
72
SNSE alert for Feb 21

Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock